Outcomes with P2Y12 inhibitors after PCI according to CYP2C19 genotype5' education - Apr. 12, 2021 - Danny Claassens, MD - Isala Hospital, Zwolle, The Netherlands
This video was recorded in response to a recent publication in Cir Cardiovasc Interven. by Danny Claassens and colleagues.
Danny Claassens is a PhD candidate at the department of Cardiology at Isala Hospital in the Netherlands
This recording was developed under auspices of PACE-cme. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-cme.